Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression
Frontiers in Pharmacology
63 89 82 75
Miljøkjemi og helse
Kjeller
eml@nilu.no
Frontiers in Pharmacology
Frontiers in Toxicology
Frontiers in Toxicology
Frontiers in Toxicology
Small
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
Computational and Structural Biotechnology Journal
Toxicology in Vitro
Particle and Fibre Toxicology
Nanomaterials
ACTRIS Science Conference 2026
10th International WeBIOPATR Workshop and Conference 2025
10th International WeBIOPATR Workshop and Conference 2025
The CONSENSUSFRA Workshop: A pilot study on tire wear rubber additives
SSbD25 Conference
1st stakeholder board meeting
SSbD25 Conference
NanoWeek
NanoWeek
NANOTOX 2024
NILU leder et internasjonalt konsortium om risikostyring for konstruerte nanomaterialer i H2020-prosjektet RiskGONE. I tillegg til den koordinerende rollen er NILU ansvarlig for å sette opp retningslinjer for risiko-/nyttevurdering av […]
Det er behov for å fremskaffe et godt vitenskapelig grunnlag for å beregne risiko for de som er eksponert til nanomaterialer (NMs), for å informere regulatoriske myndigheter samt å sikre […]
Frontiers in Pharmacology
Frontiers in Toxicology
Frontiers in Toxicology
Frontiers in Toxicology
Small
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
Computational and Structural Biotechnology Journal
Toxicology in Vitro
Particle and Fibre Toxicology
Nanomaterials
ACTRIS Science Conference 2026
10th International WeBIOPATR Workshop and Conference 2025
10th International WeBIOPATR Workshop and Conference 2025
The CONSENSUSFRA Workshop: A pilot study on tire wear rubber additives
SSbD25 Conference
1st stakeholder board meeting
SSbD25 Conference
NanoWeek
NanoWeek
NANOTOX 2024
NILU leder et internasjonalt konsortium om risikostyring for konstruerte nanomaterialer i H2020-prosjektet RiskGONE. I tillegg til den koordinerende rollen er NILU ansvarlig for å sette opp retningslinjer for risiko-/nyttevurdering av […]
Det er behov for å fremskaffe et godt vitenskapelig grunnlag for å beregne risiko for de som er eksponert til nanomaterialer (NMs), for å informere regulatoriske myndigheter samt å sikre […]